Stock Events

Stock Events

Acusphere

$0.000010

3

+$0.00+0% Tuesday 21:00

Statistics

Day High

0.000001

Day Low

0.000001

52W High

0.00001

52W Low

0.000001

Volume

125

Avg. Volume

0

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

Earnings

7NovExpected

Q1 2021

Q2 2021

Q3 2021

Q4 2021

Q1 2022

Q2 2022

Q3 2022

0

0.33

0.67

1

Expected EPS

0

Actual EPS

0

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ACUS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Novartis is involved in the development of healthcare solutions including drug delivery technologies similar to Acusphere's, making them direct competitors in the pharmaceuticals market.

Pfizer develops advanced drug delivery systems and pharmaceuticals that compete with Acusphere's product offerings.

Johnson & Johnson

Johnson & Johnson, through its pharmaceutical division, competes in the same space as Acusphere, particularly in the innovation of drug delivery technologies.

Merck produces drugs and technologies that directly compete with Acusphere's specialty in pharmaceutical formulations.

Abbott Laboratories

Abbott Laboratories offers medical devices and pharmaceuticals that overlap with Acusphere's market, particularly in targeted drug delivery systems.

Eli Lilly and Company competes with Acusphere in the pharmaceutical sector, focusing on drug delivery and formulation.

Bristol-Myers Squibb

Bristol-Myers Squibb operates in the same pharmaceutical and biotechnology areas as Acusphere, making them a competitor in drug delivery innovations.

GlaxoSmithKline focuses on developing drugs and formulations that compete with Acusphere's technologies in the pharmaceutical market.

Sanofi competes with Acusphere in the global pharmaceutical market, particularly in areas involving complex drug delivery systems.

AstraZeneca is involved in the development and commercialization of pharmaceutical products that compete with Acusphere's drug delivery technologies.

About

Acusphere, Inc. is a pharmaceutical firm specializing in the creation and market launch of cardiovascular treatments. Its flagship product is Imagify (perflubutane polymer microspheres), a cardiovascular medication designed to assess myocardial perfusion and aid in the diagnosis of coronary artery disease. This drug is administered as an injectable suspension. Initially established as Polymers For Medicine, Inc., the organization rebranded as Acusphere, Inc. in March 2004. Founded in 1993, the company maintains its headquarters in Watertown, Massachusetts.

Show more...

CEO

Dr. William I. Ramage D.Phil

Employees

50

Country

United States

ISIN

US00511R8549

Listings

0 Comments

Share your thoughts

FAQ

What is Acusphere stock price today?▼

The current price of ACUS is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Acusphere stock price performance more closely on the chart.

What is Acusphere stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Acusphere stocks are traded under the ticker ACUS.

Is Acusphere stock price growing?▼

ACUS stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Acusphere has showed a +0% increase.

What were Acusphere earnings last quarter?▼

ACUS earnings for the last quarter are 0 USD per share, whereas the estimation was 0 USD resulting in a +NaN% surprise. The estimated earnings for the next quarter are N/A USD per share.

How many employees does Acusphere have?▼

As of July 11, 2026, the company has 50 employees.

In which sector is Acusphere located?▼

Acusphere operates in the Health & Wellness sector.

When did Acusphere complete a stock split?▼

Acusphere has not had any recent stock splits.

Where is Acusphere headquartered?▼

Acusphere is headquartered in Watertown, United States.